双侧胸廓内动脉用于冠状动脉血运重建的当前趋势:将获益扩展至高危患者
该回顾性研究分析了2000年1月至2015年12月在Mayo Clinic接受孤立性冠状动脉旁路移植术的多支冠状动脉病变患者,通过倾向性评分匹配比较双侧与单侧胸廓内动脉移植的生存获益。结果显示双侧胸廓内动脉使用呈上升趋势,匹配后双侧组生存获益(HR 0.81,95%CI 0.66-0.99,P=.043),且在高危亚组中未见生存不利影响。
要点
- 双侧胸廓内动脉使用率从2012年13%增至2015年27%(线性趋势P=.005)。
- 倾向性匹配后双侧胸廓内动脉组生存获益(HR 0.81,95%CI 0.66-0.99,P=.043)。
- 深部胸骨伤口感染双侧组1.2% vs 单侧组0.5%(P=.088),无统计学显著差异。
核心结论
- 冠状动脉旁路移植术中双侧胸廓内动脉的使用随时间增加,具有一致的生存获益,并扩展至合并较高风险合并症的患者,提示需要进一步扩大该技术的使用。
研究设计与样本
- 回顾性综述,纳入2000年1月至2015年12月在Mayo Clinic因多支冠状动脉病变接受孤立性冠状动脉旁路移植术的患者。
- 共6468例孤立性冠状动脉旁路移植术(5431例使用单侧胸廓内动脉,1037例使用双侧胸廓内动脉)。
- 采用倾向性评分匹配双侧胸廓内动脉与单侧胸廓内动脉组(1011对匹配)。
- 评估双侧胸廓内动脉对高危患者(射血分数<40%、体重指数≥30、年龄≥70岁、糖尿病、慢性肺病、脑血管意外)生存的影响。
主要发现
- 双侧胸廓内动脉使用呈增加趋势(线性趋势P=.005),冠状动脉旁路移植术中双侧胸廓内动脉百分比在过去4年翻倍(2012年13%至2015年27%)。
- 倾向性匹配比较显示双侧胸廓内动脉具有生存优势(风险比0.81;95%置信区间0.66-0.99;P=.043)。
- 深部胸骨伤口感染风险双侧胸廓内动脉组虽较高,但无统计学显著差异(1.2% vs 0.5%;P=.088)。
- 任何高危患者亚组均未显示双侧胸廓内动脉对生存的不利影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We sought to identify the trends in bilateral internal thoracic artery use and determine the degree to which the survival advantage of bilateral internal thoracic artery revascularization persists among perceived "high-risk" patients, compared with the use of left internal thoracic artery alone. METHODS: A retrospective review was conducted of patients who underwent isolated coronary artery bypass grafting for multivessel coronary artery disease at the Mayo Clinic between January 2000 and December 2015. Propensity score matching was performed between patients with bilateral internal thoracic artery and left internal thoracic artery alone grafts (1011 matched pairs). Effect of bilateral internal thoracic artery use on survival in "high-risk" patients (ejection fraction <40%, body mass index ≥30, age ≥70 years, diabetes, chronic lung disease, cerebrovascular accident) was evaluated. RESULTS: A total of 6468 isolated coronary artery bypass grafts were performed (5431 using left internal thoracic artery alone, 1037 using bilateral internal thoracic artery). There was an increasing trend in bilateral internal thoracic artery use (P value for linear trend = .005), with the percentage of coronary artery bypass grafting cases with bilateral internal thoracic artery doubling over the last 4 years (13% in 2012 to 27% in 2015). Propensity-matched comparisons showed a survival advantage for bilateral internal thoracic artery (hazard ratio, 0.81; 95% confidence interval, 0.66-0.99; P = .043). Risk of deep sternal wound infection, although higher in the bilateral internal thoracic artery group, was not significant (1.2% vs 0.5%; P = .088). None of the "high-risk" subsets of patients showed an adverse effect of bilateral internal thoracic artery on survival. CONCLUSIONS: Bilateral internal thoracic artery use in coronary artery bypass grafting is increasing over time. There is a consistent survival benefit with bilateral internal thoracic artery use, extending to patients with higher-risk comorbidities, suggesting the need for further expansion in use of this technique.
引用
- Saran N, Locker C, Said SM, et al. Current trends in bilateral internal thoracic artery use for coronary revascularization: Extending benefit to high-risk patients. J Thorac Cardiovasc Surg. 2018. PMID: 29551541. doi:10.1016/j.jtcvs.2018.01.094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。